Library

4F-MABP

4F-MABP is a little-studied fluorinated analogue of buphedrone first identified on the European NPS market in 2014. Animal data and seizure analyses show it acts as a dopamine and norepinephrine reuptake inhibitor comparable in potency to flephedrone. Human reports are scarce; effects resemble other short-acting cathinones with rapid onset euphoria, strong urge to redose, and an uncomfortable crash. Because no pharmacological or toxicological studies in humans exist, dosing should start low. Users have reported pronounced peripheral vasoconstriction and tachycardia.

Also known as: 4-fbp, 4-fluorobuphedrone, Para-fluorobuphedrone, 4F‑buphedrone, 4-Fluorobephedrone

Classification

  • Chemical: Cathinone
  • Chemical: Phenethylamine
  • Psychoactive: Stimulant
  • Tag: Research-Chemical

Effects

  • Stimulation
  • Vasoconstriction
  • Temperature Regulation Suppression
  • Teeth Grinding
  • Jaw Clenching
  • Increased Heart Rate
  • Euphoria
  • Focus Enhancement
  • Motivation Enhancement
  • Increased Sociability
  • Talkativeness
  • Empathy Enhancement
  • Music Appreciation Enhancement
  • Increased Libido
  • Appetite Suppression
  • Dehydration
  • Increased Music Appreciation
  • Light Sensitivity

Routes of Administration

Oral

Dosage

  • Threshold: 20 mg
  • Light: 30 – 60 mg
  • Common: 60 – 120 mg
  • Strong: 120 – 180 mg
  • Heavy: 180 mg +

Duration

  • Onset: 0.25-0.5 h
  • Comeup: 0.5-0.75 h
  • Peak: 1-2 h
  • Offset: 2-3.5 h
  • After Effects: 2-6 h
  • Total Duration: 3-5 h

Insufflated

Dosage

  • Threshold: 10 mg
  • Light: 15 – 30 mg
  • Common: 30 – 70 mg
  • Strong: 70 – 120 mg
  • Heavy: 120 mg +

Duration

  • Onset: 0.033-0.083 h
  • Comeup: 0.17-0.33 h
  • Peak: 0.5-1.5 h
  • Offset: 0.5-1 h
  • After Effects: 2-6 h
  • Total Duration: 2-4 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

4F-MABP - Guide des substances DrugsPRO

4F-MABP: 4F-MABP is a little-studied fluorinated analogue of buphedrone first identified on the European NPS market in 2014. Animal data and seizure analyses show it acts as a dopamine and norepinephrine reuptake inhibitor comparable in potency to flephedrone. Human reports are scarce; effects resem

Related pages